Epirubicin HCl | 盐酸表柔比星 | 4'-Epidoxorubicin hydrochloride | DNA/RNA Synthesis Inhibitor

首页 / / / / Epirubicin HCl

表阿霉素盐酸盐 /Epirubicin HCl {[allProObj[0].p_purity_real_show]}

货号：A263227 同义名： 盐酸表柔比星 / 4'-Epidoxorubicin hydrochloride;Epirubicin (hydrochloride)

Epirubicin HCl, a L-arabino derivative of doxorubicin, can inhibit topoisomerase and used as antineoplastic agent.

Epirubicin HCl 化学结构
CAS号：56390-09-1

Epirubicin HCl 3D分子结构
CAS号：56390-09-1

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Epirubicin HCl 纯度/质量文件产品仅供科研

货号：A263227 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]; • JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]; • BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]; • J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]; • PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]; 更多 >

拓扑异构酶亚型比较

产品名称	Topo I ↓ ↑	Topo II ↓ ↑	Topo IV ↓ ↑	Topoisomerase ↓ ↑	其他靶点	纯度
Ellagic acid	✔					98%
β-Lapachone	✔					99%+
(s)-10-hydroxycamptothecin	✔					98+%
Camptothecin	++ Topo I, IC50: 0.68 μM					98%
Betulinic acid	++ Eukaryotic topoisomerase I, IC50: 5 μM					98%
Topotecan	++++ Topo I (DU-145 Luc cells), IC50: 2 nM Topo I (MCF-7 Luc cells), IC50: 13 nM					98%
Irinotecan HCl Trihydrate	✔					98%
SN-38	✔					98%
Levofloxacin hydrate		✔				98%
Dexrazoxane		✔				99%+
Ofloxacin		✔				98+%
Enoxacin		✔				99%+
Flumequine		+ Topo II, IC50: 15 μM				98%
Levofloxacin		✔				97%
Etoposide		✔				98%
Pefloxacin mesylate dihydrate		✔				99+%
Marbofloxacin		✔				98+%
Voreloxin HCl		✔				98%
Mitoxantrone dihydrochloride		✔			PKC	98%
Nalidixic acid		✔				98%
Doxorubicin		✔				98%
Novobiocin sodium		✔				95%
Amonafide		✔				99%+
Pirarubicin		✔				98%+
Idarubicin HCl		+++ Topo II (MCF-7 cells), IC50: 3.3 ng/mL				99%+
Genistein		✔			EGFR	98%
Teniposide		✔				98%
Moxifloxacin		✔				98%
Ciprofloxacin			✔			98%
Clinafloxacin			✔			97%
Gatifloxacin				✔		98%
Daunorubicin HCl				+++ DNA synthesis, Ki: 20 nM		98%
Epirubicin HCl				✔		99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Epirubicin HCl 生物活性

靶点

Topoisomerase

描述

Epirubicin, a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase^[3]. Epirubicin inhibits DNA and RNA synthesis. Epirubicin is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity{ Kashima H, Momose F, Umehara H, et al. Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity. PLoS One. 2016;11(6):e0156643. |https://pubmed.ncbi.nlm.nih.gov/27284967/}}. Epirubicin is cytotoxic to Hepatoma G2 cells with IC50 of 1.6 μg/mL at 24 hr. 1.6 μg/mL Epirubicin induces apoptosis of Hep G2 cells, and higher activity of catalase by 50%, Se-dependent glutathione peroxidase by 110%, Cu, Zn-superoxide dismutase by 172% and Mn-superoxide dismutase by 135%^[4]. Epirubicin at a dose of 3.5 mg/kg suppresses tumor mass of human breast tumor xenograft R-27 by 74.4 %^[5].

Epirubicin HCl 细胞研究

细胞系	浓度	检测类型	检测时间	活动说明	数据源
human A549 cells		Proliferation assay	48 h	Antiproliferative activity against human A549 cells after 48 hrs by MTT assay, IC50=9.6 μM	23287057
human DU145 cells		Proliferation assay	48 h	Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay, IC50=9.9 μM	23287057
human HCT116 cells		Cytotoxic assay	6 days	Cytotoxicity against human HCT116 cells after 6 days by MTT assay, IC50=0.82 μM	22276679
human Hep3B cells		Cytotoxic assay	6 days	Cytotoxicity against human Hep3B cells after 6 days by MTT assay, IC50=0.96 μM	22276679

Epirubicin HCl 参考文献

[1]Ozkan A, Fişkin K. Epirubicin HCl toxicity in human-liver derived hepatoma G2 cells. Pol J Pharmacol. 2004 Jul-Aug;56(4):435-44.

[2]Cersosimo RJ, Hong WK. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol. 1986 Mar;4(3):425-39.

[3]Cersosimo RJ, Hong WK. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol. 1986;4(3):425-439.

[4]Ozkan A, Fişkin K. Epirubicin HCl toxicity in human-liver derived hepatoma G2 cells. Pol J Pharmacol. 2004;56(4):435-444.

[5]Bonadonna G, Gianni L, Santoro A, et al. Drugs ten years later: epirubicin. Ann Oncol. 1993;4(5):359-369.

Epirubicin HCl 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

1.72mL

0.34mL

0.17mL

8.62mL

1.72mL

0.86mL

17.24mL

3.45mL

1.72mL

Epirubicin HCl 技术信息

CAS号	56390-09-1
分子式	C₂₇H₃₀ClNO₁₁
分子量	579.98

别名	盐酸表柔比星 ;4'-Epidoxorubicin hydrochloride;Epirubicin (hydrochloride);4’-Epidoxorubicin;4'-epidoxorubicin HCl;NSC 256942 HCl;IMI 28 HCl;Epirubicin hydrochloride
运输	蓝冰

存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Inert atmosphere,Store in freezer, under -20°C

溶解度

DMSO: 25 mg/mL(43.1 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

H₂O: 50 mg/mL(86.21 mM)，配合低频超声助溶

动物实验配方

PO 0.5% CMC-Na 12 mg/mL suspension

细胞研究

细胞系	浓度	检测类型	检测时间	活动说明	数据源

human A549 cells		Proliferation assay	48 h	Antiproliferative activity against human A549 cells after 48 hrs by MTT assay, IC50=9.6 μM	23287057
human DU145 cells		Proliferation assay	48 h	Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay, IC50=9.9 μM	23287057
human HCT116 cells		Cytotoxic assay	6 days	Cytotoxicity against human HCT116 cells after 6 days by MTT assay, IC50=0.82 μM	22276679
human Hep3B cells		Cytotoxic assay	6 days	Cytotoxicity against human Hep3B cells after 6 days by MTT assay, IC50=0.96 μM	22276679
human HepG2 cells		Cytotoxic assay	6 days	Cytotoxicity against human HepG2 cells after 6 days by MTT assay, IC50=1.65 μM	22276679
human HepG2 cells		Proliferation assay	48 h	Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay, IC50=4.6 μM	23287057
human MCF7 cells		Proliferation assay	48 h	Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay, IC50=3.7 μM	23287057
human MCF7 cells	5 μM	Cytotoxic assay	48 h	Cytotoxicity against human MCF7 cells assessed as change in cell viability at 5 uM after 48 hrs by MTT assay	23287057
human MCF7/ADR cells		Cytotoxic assay	6 days	Cytotoxicity against human MCF7/ADR cells after 6 days by MTT assay, IC50=1.65 μM	22276679
human MDA-MB-231 cells		Proliferation assay	48 h	Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay, IC50=5.6 μM	23287057
human MDA-MB-231 cells	5 μM	Cytotoxic assay	48 h	Cytotoxicity against drug-resistant human MDA-MB-231 cells assessed as change in cell viability at 5 uM after 48 hrs by MTT assay	23287057
human PC3 cells		Cytotoxic assay	6 days	Cytotoxicity against human PC3 cells after 6 days by MTT assay, IC50=0.46 μM	22276679
human PC3 cells		Proliferation assay	48 h	Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay, IC50=5.7 μM	23287057
human T47D cells		Proliferation assay	48 h	Antiproliferative activity against human T47D cells after 48 hrs by MTT assay, IC50=4.3 μM	23287057
human T47D cells	5 μM	Cytotoxic assay	48 h	Cytotoxicity against human T47D cells assessed as change in cell viability at 5 uM after 48 hrs by MTT assay	23287057
MCF-7 cells		Cytotoxic assay		Compound was tested for its toxicity against human breast cancer cells(MCF-7), IC50=0.2 μM	9548820
NIH/3T3 cells		Proliferation assay	48 h	Antiproliferative activity against mouse NIH/3T3 cells after 48 hrs by MTT assay, IC50=4.2 μM	23287057

表阿霉素盐酸盐 /Epirubicin HCl {[allProObj[0].p_purity_real_show]}

Epirubicin HCl 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Epirubicin HCl 质控信息

Epirubicin HCl 生物活性

Epirubicin HCl 细胞研究

Epirubicin HCl 参考文献

Epirubicin HCl 实验方案

Epirubicin HCl 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

表阿霉素盐酸盐 /Epirubicin HCl {[allProObj[0].p_purity_real_show]}

Epirubicin HCl 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Epirubicin HCl 质控信息

Epirubicin HCl 生物活性

Epirubicin HCl 细胞研究

Epirubicin HCl 参考文献

Epirubicin HCl 实验方案

Epirubicin HCl 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Epirubicin HCl 纯度/质量文件产品仅供科研